Prognostic factors in oropharyngeal squamous cell carcinoma in the state of São Paulo, Brazil: 10-year follow-up

AUTOR(ES)

Lau, Fabio; Tamanini, Jonas Belchior; Gazmenga, Fabio Portella; Mercuri, Gustavo; Oliveira, Vanessa Carvalho de; Teixeira, Daniel Naves Araújo; Couto, Eduardo Vieira; Chone, Carlos Takahiro

FONTE

Brazilian Journal of Otorhinolaryngology

DATA DE PUBLICAÇÃO

2022

RESUMO

Abstract Objective: To descriptively analyze the epidemiological data, clinical stage, and outcomes of oropharyngeal squamous cell carcinoma in the state of São Paulo, Brazil, and to estimate the influence of clinical stage and treatment type on overall and disease-free survival. Methods: We retrospectively analyzed epidemiological data from the São Paulo Cancer Center Foundation database relative to patients with oropharyngeal squamous cell carcinoma diagnosed between 2004 and 2014 in the state of São Paulo. Univariate and multivariate Cox regression analyses were performed to assess factors associated with the outcomes. A forward stepwise selection procedure was used. Survival curves were estimated by the Kaplan-Meier method and compared by the Gehan-Breslow-Wilcoxon test. Results: A total of 8075 individuals with oropharyngeal squamous cell carcinoma were identified. Of these, 86.3% were diagnosed at an advanced stage and 13.7% at an early stage. Only 27.2% of patients were treated surgically, whereas 57.5% were treated medically. Patients undergoing surgery had longer overall survival than those receiving medical treatment in both early- and advanced-stage oropharyngeal squamous cell carcinoma. However, there was no significant difference in disease-free survival between surgical and medical treatment. Conclusion: No significant difference in disease-free survival between medical and surgical treatment suggests similar complete remission rates with both approaches. Patients receiving medical treatment had shorter overall survival, which may be due to complications from chemotherapy and radiotherapy. However, we cannot confirm this relationship based on the data provided by the São Paulo Cancer Center Foundation. Prospective studies are warranted to assess whether the lower overall survival rate in patients receiving medical treatment is secondary to complications from chemotherapy and radiotherapy. Level of evidence: 2C.

Documentos Relacionados

• Chronic bronchitis: a 10-year follow-up
• Early treatment of Class III malocclusion: 10-year clinical follow-up
• Large Bilateral Coronary Artery Fistula: 10-year Follow-up in Clinical Treatment
• Mortality rate after open Roux-in-Y gastric bypass: a 10-year follow-up
• Wilson's disease in southern Brazil: a 40-year follow-up study